- Ticker iNav Bloomberg: IVWCGCHF
- Bloomberg: VWCG SW
- ISIN: IE00BK5BQX27
- MEX ID: VRPURC
- Reuters: VWCG.S
- SEDOL: BJSBDH5
- Exchange ticker: VWCG
FTSE Developed Europe UCITS ETF - (EUR) Accumulating (VWCG)
Related Documents
NAV Price ()
—
Market value ()
—
—
Number of stocks
—
Start a savings plan or make a one-off investment
Invest now with an online broker
Learn moreAbout this fund
Fund objectives
- The Fund employs a passive management – or indexing – investment approach, through physical acquisition of securities, and seeks to track the performance of the FTSE Developed Europe Index (the “Index”).
- The Index is comprised of large and mid-sized company stocks in developed markets in Europe.
- The Fund attempts to: 1. Track the performance of the Index by investing in all constituent securities of the Index in the same proportion as the Index. Where not practicable to fully replicate, the Fund will use a sampling process. 2. Remain fully invested except in extraordinary market, political or similar conditions.
Fund facts
Share class inception
23 Jul 2019
Listing date
25 Jul 2019
Investment structure
Irish UCITS
Share Class Assets'
Total Assets
Risk indicator
Strategy
Index
Asset Class
Equity
Investment method
Physical
Index ticker
TAWNT06E
Benchmark
FTSE Developed Europe Index
Dividend schedule
—
Tax status
Austria,Germany,Switzerland,United Kingdom reporting
Domicile
Ireland
Legal entity
Vanguard Funds PLC
The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.
Performance
Risk and Volatility
As at 31 Mar 2026
Beta
R²
Annualized Tracking Error
1 year
3 years
5 years
Please note Beta and R-squared data will only display for funds with 3 full years of history.
The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.
Portfolio data
Characteristics
| Fundamentals | Fund | Benchmark | As at |
|---|---|---|---|
| Number of stocks | 515 | 496 | 31 Mar 2026 |
| Median market capital | 73.5 B | 73.5 B | 31 Mar 2026 |
| 17.2 x | 17.2 x | 31 Mar 2026 | |
| 2.3 x | 2.3 x | 31 Mar 2026 | |
| 13.8% | 13.8% | 31 Mar 2026 | |
| 13.8% | 13.6% | 31 Mar 2026 | |
| Portfolio turnover rate | -17.7% | — | 31 Mar 2026 |
Market allocation
As at 31 Mar 2026
| Country | Region | Fund | Benchmark | Variance +/- |
|---|---|---|---|---|
| United Kingdom | Europe | 23.85% | 23.58% | 0.27% |
| France | Europe | 15.04% | 15.09% | -0.05% |
| Switzerland | Europe | 14.49% | 14.54% | -0.05% |
| Germany | Europe | 13.47% | 13.51% | -0.04% |
| Netherlands | Europe | 7.48% | 7.51% | -0.03% |
| Spain | Europe | 5.87% | 5.89% | -0.02% |
| Italy | Europe | 5.38% | 5.40% | -0.02% |
| Sweden | Europe | 5.14% | 5.17% | -0.03% |
| Denmark | Europe | 2.40% | 2.41% | -0.01% |
| Finland | Europe | 1.81% | 1.82% | -0.01% |
| Belgium | Europe | 1.74% | 1.74% | 0.00% |
| Norway | Europe | 1.16% | 1.17% | -0.01% |
| Poland | Europe | 0.74% | 0.75% | -0.01% |
| Ireland | Europe | 0.54% | 0.54% | 0.00% |
| Austria | Europe | 0.54% | 0.54% | 0.00% |
Holdings details
As at 31 Mar 2026
| Holding name | % of market value | Sector | Region | Market value | Shares |
|---|---|---|---|---|---|
| ASML Holding NV | 3.68189% | Technology | NL | €239,779,646.40 | 214,242 |
| AstraZeneca PLC | 2.13692% | Health Care | GB | €139,165,387.98 | 827,735 |
| Novartis AG | 2.12469% | Health Care | CH | €138,368,692.97 | 1,059,976 |
| HSBC Holdings PLC | 2.03573% | Financials | GB | €132,575,384.71 | 9,482,345 |
| Roche Holding AG | 2.02563% | Health Care | CH | €131,917,666.17 | 388,103 |
| Shell PLC | 1.97907% | Energy | GB | €128,885,007.10 | 3,142,950 |
| Nestle SA | 1.84824% | Consumer Staples | CH | €120,365,192.46 | 1,421,068 |
| Siemens AG | 1.28081% | Industrials | DE | €83,411,967.10 | 405,503 |
| SAP SE | 1.28027% | Technology | DE | €83,376,326.80 | 567,572 |
| TotalEnergies SE | 1.24520% | Energy | FR | €81,092,856.60 | 1,002,260 |
Prices and distribution
Prices
NAV Price (EUR)
€56.39
Change
-€0.02-0.04% At closure 16 Apr 2026
Market value (CHF)
CHF 52.15
Change
-CHF 0.06-0.11% At closure 16 Apr 2026
NAV 52-week high
€57.71
At closure 16 Apr 2026
Market value 52-week high
CHF 52.70
At closure 16 Apr 2026
NAV 52-week low
€45.03
At closure 16 Apr 2026
Market value 52-week low
CHF 42.11
At closure 16 Apr 2026
NAV 52-week difference
€12.67
Change
+21.96% At closure 16 Apr 2026
Market value 52-week difference
CHF 10.59
Change
+20.09% At closure 16 Apr 2026
Outstanding shares
42,884,714
At closure 31 Mar 2026
Historical Prices
-
Inception date
23 Jul 2019
Listing date
16 Sep 2021
| Date | NAV (EUR) | Market price (CHF) |
|---|---|---|
| 16 Apr 2026 | €56.3899 | CHF 52.1500 |
| 15 Apr 2026 | €56.4122 | CHF 52.2100 |
| 14 Apr 2026 | €56.6724 | CHF 52.3300 |
| 13 Apr 2026 | €56.1172 | CHF 51.8800 |
| 10 Apr 2026 | €56.2068 | CHF 52.2400 |
| 09 Apr 2026 | €55.9795 | CHF 51.5900 |
| 08 Apr 2026 | €56.0370 | CHF 51.7800 |
| 07 Apr 2026 | €53.9290 | CHF 49.9050 |
| 06 Apr 2026 | €54.5145 | — |
| 02 Apr 2026 | €54.4911 | CHF 49.6800 |
Distribution history
Distribution frequency
—
Historical performance
—
All dividends are reinvested for the "Accumulation" shares.
Purchase information
Currencies and stock exchanges
Listed currencies: EUR, GBP, USD, CHF
Base currency: EUR
Exchanges: NYSE Euronext - Amsterdam, London Stock Exchange, Deutsche Boerse, Bolsa Institucional De Valores, Borsa Italiana S.p.A., SIX Swiss Exchange